-
1دورية أكاديمية
المؤلفون: Irakoze Ange, Mugwaneza Placidie, Nsanzimana Sabin, Mbabzi Jennifer, Nyemazi Jean, Remera Eric
المصدر: Retrovirology, Vol 9, Iss Suppl 1, p P100 (2012)
مصطلحات موضوعية: Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1742-4690Test
-
2دورية أكاديمية
المؤلفون: Irakoze Ange, Tuyishimire Diane, Bugingo B, Nsanzimana Sabin, Maliboli M, Muhizi Melanie, Nkuliza Angelique, Niyonsenga Simon, Gasana M, Baribwira Ciprien, Sebeza Jackson, Umulisa Laetitia
المصدر: Retrovirology, Vol 9, Iss Suppl 1, p P102 (2012)
مصطلحات موضوعية: Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1742-4690Test
-
3تقرير
المؤلفون: Mutesa, Leon, Ndishimye, Pacifique, Butera, Yvan, Souopgui, Jacob, Uwineza, Annette, Rutayisire, Robert, Musoni, Emile, Rujeni, Nadine, Nyatanyi, Thierry, Ntagwabira, Edouard, Semakula, Muhammed, Musanabaganwa, Clarisse, Nyamwasa, Daniel, Ndashimye, Maurice, Ujeneza, Eva, Mwikarago, Ivan Emile, Muvunyi, Claude Mambo, Mazarati, Jean Baptiste, Nsanzimana, Sabin, Turok, Neil, Ndifon, Wilfred
مصطلحات موضوعية: Quantitative Biology - Quantitative Methods, Quantitative Biology - Populations and Evolution
الوصول الحر: http://arxiv.org/abs/2004.14934Test
-
4دورية أكاديمية
المؤلفون: Gasasira Rwego A, Sarker Malabika, Tsague Landry, Nsanzimana Sabin, Gwiza Aimée, Mbabazi Jennifer, Karema Corine, Asiimwe Anita, Mugwaneza Placidie
المصدر: BMC Public Health, Vol 12, Iss 1, p 134 (2012)
مصطلحات موضوعية: Male Circumcision, HIV/AIDS, HIV Prevention, Rwanda, Public aspects of medicine, RA1-1270
وصف الملف: electronic resource
-
5دورية أكاديمية
المساهمون: SEMAKULA, Muhammed, Niragire, Francois, Nsanzimana, Sabin, Remera, Eric, FAES, Christel
مصطلحات موضوعية: COVID-19, Spatio-temporal models, Epidemiology
وصف الملف: application/pdf
العلاقة: info:eu-repo/grantAgreement/EC/H2020/101003688; BMC PUBLIC HEALTH, 23 (1) (Art N° 930); http://hdl.handle.net/1942/40419Test; 23; 000993874800003
-
6دورية أكاديمية
المؤلفون: The COVID-19 Consensus Statement Panel, Lazarus, Jeffrey V., Romero, Diana, Kopka, Christopher J., Karim, Salim Abdool, Abu-Raddad, Laith J., Almeida, Gisele, Baptista-Leite, Ricardo, Barocas, Joshua A., Barreto, Mauricio L., Bar-Yam, Yaneer, Bassat, Quique, Batista, Carolina, Bazilian, Morgan, Chiou, Shu Ti, del Rio, Carlos, Dore, Gregory J., Gao, George F., Gostin, Lawrence O., Hellard, Margaret, Jimenez, Jose L., Kang, Gagandeep, Lee, Nancy, Matičič, Mojca, McKee, Martin, Nsanzimana, Sabin, Oliu-Barton, Miquel, Pradelski, Bary, Pyzik, Oksana, Rabin, Kenneth, Raina, Sunil, Rashid, Sabina Faiz, Rathe, Magdalena, Saenz, Rocio, Singh, Sudhvir, Trock-Hempler, Malene, Villapol, Sonia, Yap, Peiling, Binagwaho, Agnes, Kamarulzaman, Adeeba, El-Mohandes, Ayman, Barreto, Mauricio, Abdulla, Salim, Addleman, Sarah, Aghayeva, Gulnara, Agius, Raymond, Ahmed, Mohammed, Ramy, Mohamed Ahmed, Garcia, Patricia, Heino, Matti T.J.
المساهمون: Helsinki Collegium for Advanced Studies, Research Group of Nelli Hankonen, Doctoral Programme in Social Sciences, Academic Disciplines of the Faculty of Social Sciences
مصطلحات موضوعية: 3142 Public health care science, environmental and occupational health
وصف الملف: application/pdf
العلاقة: J.V.L. reports research grants to his institution from AbbVie, Gilead Sciences and MSD, and speaker fees from AbbVie, Gilead Sciences, Intercept, Janssen, MSD and ViiV, and an advisory board fee from AbbVie and Novavax, all unrelated to this work. R.A. is a co-chair of the Occupational Medicine Committee of the British Medical Association and a member of the Industrial Injuries Advisory Council (UK). S.A. reports honoraria for lectures and educational events from Gilead, AbbVie, MSD and Biogen, and reports grants, not related to COVID-19, from Gilead and AbbVie. The A.G.-S. laboratory has received research support from Pfizer, Senhwa Biosciences, Kenall Manufacturing, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold, Model Medicines, Atea Pharma, Applied Biological Laboratories and Merck. A.G.-S. has consulting agreements for the following companies involving cash and/or stock: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, Paratus, CureLab Oncology, CureLab Veterinary, Synairgen and Pfizer. A.G.-S. has been an invited speaker in meeting events organized by Seqirus, Janssen and AstraZeneca. A.G.-S. is listed as an inventor on patents and patent applications (US patent numbers: 5,820,871; 5,854,037; 6,001,634; 6,146,642; 6,451,323; 6,468,544; 6,544,785; 6,573,079; 6,635,416; 6,649,372; 6,669,943; 6,740,519; 6,852,522; 6,866,853; 6,884,414; 6,887,699; 7,060,430; 7,384,774; 7,442,379; 7,494, 808; 7,588,768; 7,833,774; 8,012,490; 8,057,803; 8,124,101; 8,137,676; 8,591,881; 8,629,283; 8,673,314; 8,709,442; 8,709,730; 8,765,139; 8,828,406; 8,999,352; 9,051,359; 9,096,585; 9,175,069; 9,217,136; 9,217,157; 9,238,851; 9,352,033; 9,371,366; 9,387,240; 9,387,242; 9,549,975; 9,701,723; 9,708,373; 9,849,172; 9,908,930; 9,968,670; 10,035,984; 10,098,945; 10,131,695; 10,137,189; 10,179,806; 10,251,922; 10,308,913; 10,543,268; 10,544,207; 10,583,188; 10,736,956; 11,254,733; and 11,266,734) on the use of antivirals and vaccines for the treatment and prevention of virus infections and cancer, owned by the Icahn School of Medicine at Mount Sinai, New York. S.G. reports being a member of Independent SAGE and member of the Pfizer Antivirals Advisory Board. P.H. reports being co-inventor of a COVID-19 recombinant protein vaccine technology owned by the Baylor College of Medicine (BCM) that was recently licenced by BCM non-exclusively and with no patent restrictions to several companies committed to advance vaccines for low- and middle-income countries. The co-inventors have no involvement in licence negotiations conducted by the BCM. Similar to other research universities, a long-standing BCM policy provides its faculty and staff, who make discoveries that result in a commercial licence, a share of any royalty income. To date, BCM has not distributed any royalty income to the co-inventors on the COVID-19 recombinant protein vaccine technology. Any such distribution will be undertaken in accordance with BCM policy. A.K. has served as a paid consultant to the Independent Panel on Pandemic Preparedness and Response in 2020–21. K.K. is Chair of the Ethnicity Subgroup of the UK Scientific Advisory Group for Emergencies (SAGE) and Member of SAGE. J.L. reports owning equity in Codiak BioSciences and Exocure Biosciences, both having developed experimental COVID-19 vaccines. G.M. reports honoraria for a presentation from Novartis and consulting fees from AstraZeneca. S.M. reports being founder and chief scientific officer of PulmoBioMed. T.S. serves as the scientific director of the O’Brien Institute for Public Health and reports funding from the Canadian Institutes of Health Research. V.S. is a member of the National Scientific Committee of Experts for COVID-19 in Greece and reports grants from Gilead and Abbvie that are not related to this work or to COVID-19 research. A.T. reports grants from the Foundation for Advancing Family Medicine Janus Research Grant; Canadian Frailty Network Research Grant, Speaking Honoraria: University of Ottawa, McMaster University, Northern Ontario School of Medicine, McGill University, University of Calgary, BC Bereavement Hotline, Early Education Teachers of Ontario-Yok Region Union, Ontario Council for Cooperation, TELUS Science World-Vancouver. R.B. has been COVID-19 adviser to UK government and acts as a senior scientific adviser for a communications company working for the UK Government on COVID-19. A.W. reports research funding from Pfizer (unrelated to COVID-19) and a consulting fee from Ocugen. K.Y. is an unpaid member of the Independent SAGE group of scientists. The other authors declare no competing interests. The chairs and core author group thank all of the panellists who completed the surveys, including for their thousands of helpful comments. They specifically thank the few panellists who are not co-authors but did actively participate in the survey rounds: K. Adolf, N. Alwan, I. Araújo, M. Brookman-Amissah, C. Caceres, M. Childs, S. Duckett, F. Farzadfar, A. Glassman, H. Hopkins, M. Kall, M. Paule Kieny, M. Malebona Precious, K. Prather, V. Priesemann, P. Ananth Tambyah, K. Yaw and S. Zhan. They further thank ISGlobal research assistants L. van Selm, C. Pujol Martínez and R. Freiheit for support, and L. Ansley Hobbs (CUNY SPH) for technical support with the QualtricsXM platform. J.V.L., Q.B., A.L.G.-B., G.F., M.K., D.N., R.V. and T.M.W. acknowledge support to ISGlobal from the Spanish Ministry of Science, Innovation and Universities through the “Centro de Excelencia Severo Ochoa 2019–2023” Programme (CEX2018-000806-S), and from the Government of Catalonia, Spain, through the CERCA Programme. J.S. acknowledges support from J. Waller for his contributions. No funding was received for this manuscript. We thank Wilton Park for hosting and sponsoring the virtual consensus meeting on 16 March 2022. The chairs and core author group thank all of the panellists who completed the surveys, including for their thousands of helpful comments. They specifically thank the few panellists who are not co-authors but did actively participate in the survey rounds: K. Adolf, N. Alwan, I. Araújo, M. Brookman-Amissah, C. Caceres, M. Childs, S. Duckett, F. Farzadfar, A. Glassman, H. Hopkins, M. Kall, M. Paule Kieny, M. Malebona Precious, K. Prather, V. Priesemann, P. Ananth Tambyah, K. Yaw and S. Zhan. They further thank ISGlobal research assistants L. van Selm, C. Pujol Martínez and R. Freiheit for support, and L. Ansley Hobbs (CUNY SPH) for technical support with the QualtricsXM platform. J.V.L., Q.B., A.L.G.-B., G.F., M.K., D.N., R.V. and T.M.W. acknowledge support to ISGlobal from the Spanish Ministry of Science, Innovation and Universities through the “Centro de Excelencia Severo Ochoa 2019–2023” Programme (CEX2018-000806-S), and from the Government of Catalonia, Spain, through the CERCA Programme. J.S. acknowledges support from J. Waller for his contributions. No funding was received for this manuscript. We thank Wilton Park for hosting and sponsoring the virtual consensus meeting on 16 March 2022.; The COVID-19 Consensus Statement Panel , Lazarus , J V , Romero , D , Kopka , C J , Karim , S A , Abu-Raddad , L J , Almeida , G , Baptista-Leite , R , Barocas , J A , Barreto , M L , Bar-Yam , Y , Bassat , Q , Batista , C , Bazilian , M , Chiou , S T , del Rio , C , Dore , G J , Gao , G F , Gostin , L O , Hellard , M , Jimenez , J L , Kang , G , Lee , N , Matičič , M , McKee , M , Nsanzimana , S , Oliu-Barton , M , Pradelski , B , Pyzik , O , Rabin , K , Raina , S , Rashid , S F , Rathe , M , Saenz , R , Singh , S , Trock-Hempler , M , Villapol , S , Yap , P , Binagwaho , A , Kamarulzaman , A , El-Mohandes , A , Barreto , M , del Rio , C , Abdulla , S , Addleman , S , Aghayeva , G , Agius , R , Ahmed , M , Ramy , M A , Garcia , P & Heino , M T J 2022 , ' A multinational Delphi consensus to end the COVID-19 public health threat ' , Nature , vol. 611 , no. 7935 , pp. 332-345 . https://doi.org/10.1038/s41586-022-05398-2Test; ORCID: /0000-0003-0094-2455/work/130151347; 85141893174; 26b4746b-ca69-4b2d-9e0c-352bd74d2a32; http://hdl.handle.net/10138/355215Test; 000878444000001
-
7دورية أكاديمية
المؤلفون: Peck, Megan E., Bronson, Megan, Djomand, Gaston, Basile, Ikuzo, Collins, Kamanzi, Kankindi, Ida, Kayirangwa, Eugenie, Malamba, Samuel S., Mugisha, Veronicah, Nsanzimana, Sabin, Remera, Eric, Kazaura, Kokuhumbya J., Amuri, Mbaraka, Mmbando, Susan, Mgomella, George S., Simbeye, Daimon, Colletar Awor, Anna, Biraro, Samuel, Kabuye, Geoffrey, Kirungi, Wilford, Chituwo, Omega, Hanunka, Brave, Kamboyi, Royd, Mulenga, Lloyd, Musonda, Bupe, Muyunda, Brian, Nkumbula, Tepa, Malaba, Rickie, Mandisarisa, John, Musuka, Godfrey, Peterson, Amy E., Toledo, Carlos
المساهمون: Yi, Siyan, Centers for Disease Control and Prevention
المصدر: PLOS Global Public Health ; volume 3, issue 9, page e0002326 ; ISSN 2767-3375
-
8دورية أكاديمية
المصدر: Frontiers in Digital Health ; volume 4 ; ISSN 2673-253X
مصطلحات موضوعية: Health Informatics, Medicine (miscellaneous), Biomedical Engineering, Computer Science Applications
-
9دورية أكاديمية
المؤلفون: Swan, Cynthia L., Dushimiyimana, Valentine, Ndishimye, Pacifique, Buchanan, Rachelle, Yourkowski, Anthony, Semafara, Sage, Nsanzimana, Sabin, Francis, Magen E., Thivierge, Brittany, Lew, Jocelyne, Facciuolo, Antonio, Gerdts, Volker, Falzarano, Darryl, Sjaarda, Calvin, Kelvin, David J., Bitunguhari, Leopold, Kelvin, Alyson A.
المساهمون: Government of Saskatchewan, Canadian Institutes of Health Research, Canada Foundation for Innovation
المصدر: iScience ; volume 26, issue 10, page 107959 ; ISSN 2589-0042
مصطلحات موضوعية: Multidisciplinary
الإتاحة: https://doi.org/10.1016/j.isci.2023.107959Test
https://api.elsevier.com/content/article/PII:S2589004223020369?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2589004223020369?httpAccept=text/plainTest -
10دورية أكاديمية
المؤلفون: Nachega, Jean B, Nsanzimana, Sabin, Rawat, Angeli, Wilson, Lindsay A, Rosenthal, Philip J, Siedner, Mark J, Varma, Jay K, Kilmarx, Peter H, Mutesa, Leon, Tanner, Marcel, Binagwaho, Agnes, Forrest, Jamie, Mbala-Kingebeni, Placide, Muyembe-Tamfum, Jean-Jacques, Ntoumi, Francine, Zumla, Alimuddin, de Oliveira, Tulio, Mills, Edward J
المصدر: The Lancet Infectious Diseases ; volume 23, issue 5, page e185-e189 ; ISSN 1473-3099
مصطلحات موضوعية: Infectious Diseases
الإتاحة: https://doi.org/10.1016/s1473-3099Test(22)00723-x
https://api.elsevier.com/content/article/PII:S147330992200723X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S147330992200723X?httpAccept=text/plainTest